Ka lāʻau "Tavanic". i ke aʻo

Tavanik (Analog - elefoks ole floratsid) maupaʻa i kekahi hapa o ka levofloxacin. Ka lāʻau 'Ua loaʻa ma ka papa palapala, me he kākoʻo pāʻoihana no infusion. Tavanic alakaʻi wehewehe like me ka kemikala antibacterial Agena me ka palahalaha pae o ka loa. Ka lapaʻauʻia e pili ana i na fluoroquinolones pae.

Kēia mau moʻolelo (moʻolelo) noi o ka levofloxacin kokoke loa a koke ke kemu. E ho ohana i ka ai, i uuku hopena ma completeness a me ka uku o ka omo. Ke keʻena komo iloko o na nā'aʻaʻa a me nā loko (maʻiʻaʻai, sputum, bronchial mucosa, iwi, prostate, spinal loli , etc.) he pono.

Nā hana dala o ka hana waiwai dezatsitiliruetsya a oxidized. Excretion ua advantageously lawe mai ma nā puʻupaʻa. Ma ka loaʻa 'ana o ka papa palapala o ka lāʻau no nā hola he kanaha-ewalu excreted ma ka mimi ma kahi o 87% o ka laʻau heluna aponoia ua hoʻololiʻia. Hope, he kanahiku-, elua no hora i loko o nā feces 'akomi i ka emi o 4%. Ma hope o intravenous aaieieno? Excretion ia lŘlŘ aku ma nā ka mimi i loko o ua hoʻololiʻia palapala.

Levofloxacin mea hana ku ei ka hapanui microorganisms (anaerobic, gram-oluʻolu, gram-io).

Tavanic aʻo 'aʻole i waiho aku i ka lawe ana o adolescents a me na keiki aie i ka pilikia o ka? Acaeoey o cartilage lesions ma ami. I kauoha mai ai i ka lāʻau a hiki i nā mea maʻi i loko o ka kūpuna e lawe i ka mooolelo o ka likelihood o ke alo o kāna hana o kaʻaʻa puʻuwai haʻawina.

Tavanik e ole i pono ai pākōlea hopenaʻoi loa ma ka pneumonia kiʻekiʻe degere o ka umekaumaha, kena ae la ia e pneumococcus. Me ka hui pu Inc i ke koi 'ia no ka haukapila nā mea palahēhē, hoʻonāukiuki akula ma kekahi pathogens.

E hoomanawanui i ka mea mua, ua lolo poino pili me ka loa trauma paha hahau ana, tavanic ana e hoʻonāukiuki ho'āhewa wale o convulsions. Ka pahiki o nā convulsions ua mahuahua ma concomitant pono o fenbufen, a like ia ia NSAIDs (nonsteroidal Anati-hoʻoʻino ai ') ole theophylline.

E ho ohana ana i ka lāʻau 'hiki i numbness, pōniuniu, pilikia makapō ka haunaele. Tavanic a me ka waiʻona hui hoʻonāukiuki aku i ka ulu ana o kēia mau adverse reactions i ka oi loa.

Kaiapuni lawelawe i nā mea maʻi me ka deficiency o ka monakō koko-6-posapahate dehydrogenase.

Tavanic. Na Ke Kumu: hoike

Ka hoomakaukau ana ua hoakaka ia no ka pneumonia kaiāulu-loaa, prostatitis, nā mea palahēhē huikau urinary'āpana a me nā konāhua (me pyelonephritis), ke kūʻai '-abdominal nā mea palahēhē, bacteremia (septicemia) pili me ka olelo mai pathologies.

Tavanic. Na Ke Kumu: contraindications

'Aʻole i hāʻawi ka lapaʻauʻia i hāpai keiki, epilepsy, lesions o na tendons i iapaau ana me quinolones ma ka mōʻaukala, na keiki ma lalo o umikumamawalu makahiki o ka makahiki, lactation, ka lapaʻauʻia intolerance nā mea hoʻohui.

Ke paipai laʻau heluna (intravenously ole hōʻike waha ') - kekahi i ka lā a palua 250-500 milligrams. Ke mau dala o ka lāʻau me ka nānā 'ana i ka hele ana i kahuna lapaau e pono e lawe i loko no o ka susceptibility a me ka oolea o infectious lesions.

Overdose ua hoikeia ho'āhewa wale o ke kāʻili 'ana ma luna o ka muli o epileptic kāʻili' ana, delirium, erosive lesions o ka mucous membranes, nausea. Levofloxacin uaʻaʻole e hōʻike 'ia ma ka dialysis. I ka overdosing hōʻike symptomatic Inc.

Hopena maikaʻi 'ole ma o ka erroneous pono o kekahi keu tavanic papa (250 mg) ia i hoakaka ia.

A hiki i ka hoike ana o ka adverse loa ka e pono ke ike i ka hoʻomalu.